Correlation Between Samsung Electronics and ASTELLAS PHARMA

Can any of the company-specific risk be diversified away by investing in both Samsung Electronics and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Electronics and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Samsung Electronics Co and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Samsung Electronics and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Electronics with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Electronics and ASTELLAS PHARMA.

Diversification Opportunities for Samsung Electronics and ASTELLAS PHARMA

-0.5

Correlation Coefficient

Samsung Electronics  ASTELLAS PHARMA

Very good diversification

The 3 months correlation between Samsung and ASTELLAS is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Electronics Co and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Samsung Electronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Electronics Co are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Samsung Electronics i.e., Samsung Electronics and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Samsung Electronics and ASTELLAS PHARMA

Assuming the 90 days trading horizon Samsung Electronics Co is expected to generate 0.97 times more return on investment than ASTELLAS PHARMA. However, Samsung Electronics Co is 1.03 times less risky than ASTELLAS PHARMA. It trades about 0.15 of its potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about 0.02 per unit of risk. If you would invest  71,200  in Samsung Electronics Co on April 25, 2025 and sell it today you would earn a total of  13,300  from holding Samsung Electronics Co or generate 18.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Samsung Electronics Co  vs.  ASTELLAS PHARMA UNSPADR

Samsung Electronics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Samsung Electronics Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Samsung Electronics unveiled solid returns over the last few months and may actually be approaching a breakup point.

ASTELLAS PHARMA UNSPADR

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ASTELLAS PHARMA UNSPADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical indicators, ASTELLAS PHARMA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Samsung Electronics and ASTELLAS PHARMA

The main advantage of trading using opposite Samsung Electronics and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Electronics position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.

The idea behind Samsung Electronics Co and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.